- Home
- HBNC vs ORMP Comparison
HBNC vs ORMP Comparison
Compare HBNC & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HBNC | ORMP |
|---|---|---|
| Founded | 1873 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 883.5M | 104.6M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | HBNC | ORMP |
|---|---|---|
| Price | $18.47 | $3.14 |
| Analyst Decision | Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $19.67 | N/A |
| AVG Volume (30 Days) | ★ 300.9K | 272.5K |
| Earning Date | 01-21-2026 | 11-13-2025 |
| Dividend Yield | ★ 3.46% | N/A |
| EPS Growth | N/A | ★ 838.25 |
| EPS | N/A | ★ 1.03 |
| Revenue | N/A | ★ $2,000,000.00 |
| Revenue This Year | $51.78 | N/A |
| Revenue Next Year | $7.40 | N/A |
| P/E Ratio | ★ N/A | $2.99 |
| Revenue Growth | ★ 1.91 | N/A |
| 52 Week Low | $12.70 | $1.82 |
| 52 Week High | $18.56 | $3.20 |
Technical Indicators
Market Signals| Indicator | HBNC | ORMP |
|---|---|---|
| Relative Strength Index (RSI) | 78.37 | 74.34 |
| Support Level | $16.90 | $2.66 |
| Resistance Level | $18.56 | $2.84 |
| Average True Range (ATR) | 0.41 | 0.16 |
| MACD | 0.14 | 0.03 |
| Stochastic Oscillator | 95.59 | 80.89 |
Price Performance
Historical ComparisonAbout HBNC Horizon Bancorp Inc.
Horizon Bancorp (IN) is a United States-based holding company providing banking services. It is engaged in providing commercial and retail banking services, corporate and individual trust and agency services, and other services incident to banking. The company also provides commercial loans, real estate loans, mortgage warehouse loans, consumer loans, and other credit facilities. The company has one principal business segment, commercial banking.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.